Literature DB >> 15115954

Liver fibrosis and inflammation. A review.

David Kershenobich Stalnikowitz1, Alan Bonder Weissbrod.   

Abstract

Hepatic fibrosis, is a wound healing process characterized by accumulation of extracellular matrix proteins (ECM) especially collagen types I and III, as well as an increase in other extracellular matrix constituents such as proteoglycans, fibronectin and laminin in response to liver injury. Recruitment of leukocytes takes place after the insult and requires several adhesion molecules. Monocytes and macrophages are involved in inflammatory actions by producing nitric oxide and inflammatory cytokines. As a consequence of chronic tissue damage stellate cells (SC) as well as extracellular matrix producting cells, undergo a process of activation characterized by proliferation, motility, contractility, and synthesis of extracellular matrix. Activation of SC is regulated by several soluble factors, including cytokines, chemokines, growth factors, and products of oxidative stress. TGF - b and IL- 6 are the two main fibrogenic cytokines. Potential regulatory factors of the activation of SC are important targets for future antifibrogenic treatments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15115954

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  40 in total

1.  Increased Expression of Connective Tissue Growth Factor (CTGF) in Multiple Organs After Exposure of Non-Human Primates (NHP) to Lethal Doses of Radiation.

Authors:  Pei Zhang; Wanchang Cui; Kim G Hankey; Allison M Gibbs; Cassandra P Smith; Cheryl Taylor-Howell; Sean R Kearney; Thomas J MacVittie
Journal:  Health Phys       Date:  2015-11       Impact factor: 1.316

Review 2.  Gene modulation for treating liver fibrosis.

Authors:  Kun Cheng; Ram I Mahato
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2007       Impact factor: 4.889

3.  Mislocalized scaffolding by the Na-H exchanger NHE1 dominantly inhibits fibronectin production and TGF-beta activation.

Authors:  Anastasios Karydis; Maite Jimenez-Vidal; Sheryl P Denker; Diane L Barber
Journal:  Mol Biol Cell       Date:  2009-02-18       Impact factor: 4.138

4.  RRAS: A key regulator and an important prognostic biomarker in biliary atresia.

Authors:  Rui Zhao; Hao Li; Chun Shen; Shan Zheng
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

5.  Serum endocan levels in patients with chronic liver disease.

Authors:  Duran Tok; Fuat Ekiz; Omer Basar; Sahin Coban; Gulfer Ozturk
Journal:  Int J Clin Exp Med       Date:  2014-07-15

6.  Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis.

Authors:  Jun Yu; Alex Y Hui; Eagle S H Chu; Alfred S L Cheng; Minnie Y Y Go; Henry L Y Chan; Wai K Leung; Kin F Cheung; Arthur K K Ching; Yiu L Chui; Ka K Chan; Joseph J Y Sung
Journal:  Gut       Date:  2006-12-05       Impact factor: 23.059

Review 7.  Delivery and targeting of miRNAs for treating liver fibrosis.

Authors:  Virender Kumar; Ram I Mahato
Journal:  Pharm Res       Date:  2014-09-04       Impact factor: 4.200

8.  IL-6 downregulates transcription of NTPDase2 via specific promoter elements.

Authors:  Jin Yu; Elise G Lavoie; Nina Sheung; Jacques J Tremblay; Jean Sévigny; Jonathan A Dranoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-01-17       Impact factor: 4.052

9.  Nitric oxide and MCP-1 regulation in LPS activated rat Kupffer cells.

Authors:  George Kolios; Vassilis Valatas; Pinelopi Manousou; Costas Xidakis; George Notas; Elias Kouroumalis
Journal:  Mol Cell Biochem       Date:  2008-07-16       Impact factor: 3.396

10.  Experimental obstructive cholestasis: the wound-like inflammatory liver response.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Jose García-Domínguez; Jose-Ignacio Arias; Manuel Durán; Jaime Arias
Journal:  Fibrogenesis Tissue Repair       Date:  2008-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.